
Dr. Mayank Soni
Consultant, Hemat-Oncology
About
Dr. Mayank Soni works as a Consultant in the Hemat-Oncology department at Rajiv Gandhi Cancer Institute & Research Centre in Sector-5, Rohini. His qualifications are an MBBS from University College of Medical Science and Guru Teg Bahadur Hospital, Delhi, an MD from Jawaharlal Nehru Medical College, AMU, Aligarh, a Doctorate National Board (DrNB) Clinical Hematology from RGCIRC, Delhi, and fellowships from Dharamshila Narayana Super-speciality Hospital, Delhi, in haploidentical stem cell transplant and cellular therapies, and in clinical hematology.
Acute leukaemias, lymphomas, multiple myeloma, myelodysplastic syndromes, bone marrow failure disorders, bleeding and thrombotic disorders, and graft-versus-host disease management are the conditions listed for him. Autologous and allogeneic bone marrow transplantation, haploidentical transplantation and CAR-T cell therapy are among the procedures listed for him. His special interests are clinical research and translational haematology.
The Indian Myeloma Academic Group (IMAGe) and the Society of Hematogic Oncology Woodlands USA are among his memberships. He received a University Gold Medal for distinction in his Doctor of Medicine at Jawaharlal Nehru Medical College, AMU, Aligarh, and second prizes at the National Quiz Hematology Conclave 2024 and the National Quiz Hematology Express Quiz. His earlier posts include a resident role in clinical haematology at Rajiv Gandhi Super-Speciality Hospital, Tahirpur, Delhi, fellowships in bone marrow transplantation and clinical haematology at Dharamshila Narayana Superspeciality Hospital, Delhi, and a senior resident post in haematology at ESI Basaidarapur, Delhi. His publications include work on haploidentical transplantation and donor lymphocyte infusions.
Qualifications
Awards & recognition
Publications
Response-adapted dasatinib de-escalation strategy compared to upfront Low-dose dasatinib: A prospective cohort study
Matched Unrelated Donor (MUD) Transplants Show Promising Outcomes in Thalassemia Patients Aged ≤ 12 Years
Anti‐donor antibody neutralization by donor type red cell challenge: A novel therapeutic strategy in refractory post‐transplant pure red cell aplasia
Haploidentical HSCT With Fludarabine, Melphalan 75 mg/m2 and 400 cGy TBI: A Tolerable Conditioning Regimen With Low Toxicity and Good Anti-Leukemic Activity
Real world outcome of B ALL with t (1; 19) (q23; p13)/TCF3::PBX1 in adolescents and adults treated with intensive regimes
Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID-19 lung disease
CTLA4Ig-primed donor lymphocyte infusions following haploidentical transplantation improve outcome with a distinct pattern of early immune reconstitution as compared to conventional donor lymphocyte infusions in advanced hematological malignancies
Early and Sustained Expansion of Adaptive Natural Killer Cells Following Haploidentical Transplantation and CTLA4Ig-Primed Donor Lymphocyte Infusions Dissociate Graft-versus-Leukemia and Graft-versus-Host Effects
Prophylactic oseltamivir during major seasonal influenza H1N1 outbreak might reduce both H1N1 and associated pulmonary aspergillosis in children undergoing haploidentical transplantation
Safety and efficacy of Sofosbuvir and Velpatasvir in children with active hepatitis C virus infection undergoing haploidentical transplantation
Conditions treated
Where they practise
BioTB TrustScore™ Analysis
GoodRanked #146 of 243 oncology specialists in New Delhi
Score breakdown
- Credentials & training (25%)8.0/10
postgraduate degree and fellowship or membership
- Experience & seniority (20%)3.0/10
experience not published
- Hospital standing (20%)8.4/10
Rajiv Gandhi Cancer Institute & Research Centre and NABH and NABL accredited
- Practice depth (15%)10.0/10
3 procedures listed, 7 conditions treated and academic or award record
- Access & transparency (10%)3.0/10
direct contact number
- Profile completeness (10%)8.5/10
reviewed in the last 90 days
Strengths
- Practice depth: 3 procedures listed, 7 conditions treated and academic or award record
- Profile completeness: reviewed in the last 90 days
- Hospital standing: Rajiv Gandhi Cancer Institute & Research Centre and NABH and NABL accredited
Check before you visit
- Experience & seniority: experience not published
- Access & transparency: direct contact number
BioTB analysis
Dr. Mayank Soni ranks #146 of 243 oncology specialists in New Delhi on the BioTB TrustScore™. The score of 6.9 (Good) is driven most by practice depth (10/10: 3 procedures listed, 7 conditions treated and academic or award record). The main gap is access & transparency (3/10: direct contact number), so confirm those details with the hospital before you visit.
TrustScore™ is computed by the BioTB analysis engine from the facts on this profile, weighted as shown above, and re-ranked against every other oncology specialist in New Delhi. How TrustScore™ works
Practice Location & Google Map
Address and map for this listing. Confirm before you visit.
D-18, Sector-5, Rohini, Delhi-110085
Patient Reviews0
No pay-to-rank.
BioTB TrustScore™
Computed by the BioTB analysis engine from this profile's facts and ranked against every doctor of the same specialty in New Delhi. Full analysis
Consultation details
Timings not listed. Call the clinic to confirm OPD days.
Every fact on this profile is sourced from the hospital or clinic's official website and other authoritative public pages, curated by the BioTB editorial team, scored by the TrustScore™ engine and dated at its last review. Rankings cannot be bought.
Where this information comes from
Last reviewed- Rajiv Gandhi Cancer Institute & Research Centre doctor profile (Hospital website, read 2026-10-20)
- Rajiv Gandhi Cancer Institute & Research Centre contact page (Hospital website, read 2026-10-20)
Details such as timings and fees can change, so please confirm with the clinic before you visit. If you are this doctor and something is out of date, request an update. Spotted a mistake? Tell us.
Questions about Dr. Mayank Soni
Where does Dr. Mayank Soni consult?
Dr. Mayank Soni works at Rajiv Gandhi Cancer Institute & Research Centre in Sector-5, Rohini, Delhi.
What are Dr. Mayank Soni's qualifications?
He holds an MBBS from University College of Medical Science and Guru Teg Bahadur Hospital, Delhi, an MD from Jawaharlal Nehru Medical College, AMU, Aligarh, and a Doctorate National Board (DrNB) Clinical Hematology from RGCIRC, Delhi.
Which conditions does Dr. Mayank Soni treat?
Among the listed conditions are acute leukaemias, lymphomas, multiple myeloma, myelodysplastic syndromes, bone marrow failure disorders, bleeding and thrombotic disorders, and graft-versus-host disease management.
Other oncologists near Rohini

Dr. Sudhir Kumar Rawal
Chief of GenitoUro – Oncology Services, Uro-Genito Oncology
Dr. Sudhir Kumar Rawal, Uro-Genito Oncology at Rajiv Gandhi Cancer Institute & Research Centre, Delhi, with 36 years of experience and an M.Ch. (Urology).

Dr. A.K. Dewan
Principal Director, Surgical Oncology
Dr. A.K. Dewan, Surgical Oncology at Rajiv Gandhi Cancer Institute & Research Centre, Delhi, with 40 years of experience in cancer surgery.

Dr. Shivendra Singh
Director, Surgical Oncology & Chief, GI & HPB Onco Surgery, GI & HPB Onco Surgery
Dr. Shivendra Singh, Oncology at Rajiv Gandhi Cancer Institute & Research Centre, Delhi, with 28 years of experience and a DNB (General Surgery).